RecruitingNCT06121544

The Swedish BioFINDER - Preclinical AD Study

Studying Early-onset autosomal dominant Alzheimer disease

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Skane University Hospital
Intervention
Plasma tau(diagnostic_test)
Enrollment
800 enrolled
Eligibility
50-80 years · All sexes
Timeline
20222026

Study locations (1)

Collaborators

Lund University

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06121544 on ClinicalTrials.gov

Other trials for Early-onset autosomal dominant Alzheimer disease

Additional recruiting or active studies for the same condition.

See all trials for Early-onset autosomal dominant Alzheimer disease

← Back to all trials